Hypothalamus, hypocretins/orexin, and vigilance control

Handbook of Clinical Neurology

Volumn 99, Issue C, 2011, Pages 765-782

  Nishino, Seiji ^a,b  

^a Stanford California and Cofounder   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ANIMAL; AROUSAL; BOOK; CHEMISTRY; HISTOLOGY; HUMAN; HYPOTHALAMUS; METABOLISM; PHYSIOLOGY; SLEEP; WAKEFULNESS;

ANIMALS; AROUSAL; HISTAMINE; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; SLEEP; WAKEFULNESS;

EID: 78149368004     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52007-4.00006-0     Document Type: Book

References (142)

1. Abrahamson E.E., Leak R.K., Moore R.Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 2001, 12:435-440.
2. Alam M.N., Gong H., Alam T., et al. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol 2002, 538:619-631.
3. Aldrich M., Naylor M. Narcolepsy associated with lesions of the diencephalon. Neurology 1989, 39:1505-1508.
4. Balasko M., Szelenyi Z., Szekely M. Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol Hung 1999, 86:219-222.
5. Basheer R., Rainnie D.G., Porkka-Heiskanen T., et al. Adenosine, prolonged wakefulness, and A1-activated NF-kappaB DNA binding in the basal forebrain of the rat. Neuroscience 2001, 104:731-739.
6. Bayer L., Eggermann E., Serafin M., et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001, 14:1571-1575.
7. Bayer L., Eggermann E., Serafin M., et al. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices. Neuroscience 2005, 130:807-811.
8. Benington J.H., Heller H.C. Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 1995, 45:347-360.
9. Bernardis L.L., Bellinger L.L. The dorsomedial hypothalamic nucleus revisited: 1998 update. Proc Soc Exp Biol Med 1998, 218:284-306.
10. Borbely A.A., Tobler I. Endogenous sleep-promoting substances and sleep regulation. Physiol Rev 1989, 69:605-670.
11. Borbely A.A., Wirz-Justice A. Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation. Hum Neurobiol 1982, 1:205-210.
12. Bourgin P., Huitron-Resendiz S., Spier A.D., et al. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000, 20:7760-7765.
13. Boutrel B., Kenny P.J., Specio S.E., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005, 102:19168-19173.
14. Brown R.E., Stevens D.R., Haas H.L. The physiology of brain histamine. Prog Neurobiol 2001, 63:637-672.
15. Chamberlin N.L., Arrigoni E., Chou T.C., et al. Effects of adenosine on GABAergic synaptic inputs to identified ventrolateral preoptic neurons. Neuroscience 2003, 119:913-918.
16. Chemelli R.M., Willie J.T., Sinton C.M., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
17. Cheng M.Y., Bullock C.M., Li C., et al. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417:405-410.
18. Chou T.C., Bjorkum A.A., Gaus S.E., et al. Afferents to the ventrolateral preoptic nucleus. J Neurosci 2002, 22:977-990.
19. Czeisler C.A., Duffy J.F., Shanahan T.L., et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999, 284:2177-2181.
20. De Lecea L., Kilduff T.S., Peyron C., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998, 95:322-327.
21. Dijk D.J., Czeisler C.A. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci Lett 1994, 166:63-68.
22. Dijk D.J., Boulos Z., Eastman C.I., et al. Light treatment for sleep disorders: consensus report. II. Basic properties of circadian physiology and sleep regulation. J Biol Rhythms 1995, 10:113-125.
23. Edgar D.M., Dement W.C., Fuller C.A. Effect of SCN-lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J Neurosci 1993, 13:1065-1079.
24. Edwards C.M., Abusnana S., Sunter D., et al. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 1999, 160:R7-R12.
25. Eggermann E., Serafin M., Bayer L., et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001, 108:177-181.
26. Eriksson K.S., Sergeeva O., Brown R.E., et al. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001, 21:9273-9279.
27. Espana R.A., Plahn S., Berridge C.W. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res 2002, 943:224-236.
28. Espana R.A., Valentino R.J., Berridge C.W. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 2003, 121:201-217.
29. Estabrooke I.V., McCarthy M.T., Ko E., et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001, 21:1656-1662.
30. Fujiki N., Ripley B., Yoshida Y., et al. Effect of systemic and central administration of hypocretin-1 in narcoleptic (Hcrtr 2 mutated) and control dogs. Sleep 2001, 24(Suppl)):A96-A97.
31. Fujiki N., Yoshida Y., Ripley B., et al. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. NeuroReport 2001, 12:993-997.
32. Gallopin T., Luppi P.H., Cauli B., et al. The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A(2A) receptors in the ventrolateral preoptic nucleus. Neuroscience 2005, 134:1377-1390.
33. Gaus S.E., Strecker R.E., Tate B.A., et al. Ventrolateral preoptic nucleus contains sleep-active, galaninergic neurons in multiple mammalian species. Neuroscience 2002, 115:285-294.
34. Gerashchenko D., Kohls M.D., Greco M., et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001, 21:7273-7283.
35. Hagan J.J., Leslie R.A., Patel S., et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci U S A 1999, 96:10911-10916.
36. Hara J., Beuckmann C.T., Nambu T., et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
37. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
38. Harrison T.A., Chen C.T., Dun N.J., et al. Hypothalamic orexin A-immunoreactive neurons project to the rat dorsal medulla. Neurosci Lett 1999, 273:17-20.
39. Hayaishi O., Urade Y. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 2002, 8:12-15.
40. 1 receptors in patients with Alzheimer's disease assessed by positron emission tomography. Neuroscience 2000, 99:721-729.
41. Hobson J.A., McCarley R.W., Wyzinski P.W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975, 189:55-58.
42. Huang Z.L., Qu W.M., Li W.D., et al. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001, 98:9965-9970.
43. Ida T., Nakahara K., Katayama T., et al. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res 1999, 821:526-529.
44. Inagaki N., Yamatodani A., Ando-Yamamoto M., et al. Organization of histaminergic fibers in the rat brain. J Comp Neurol 1988, 273:283-300.
45. Jones B.E. Basic mechanism of sleep-wake states. Principles and Practice of Sleep Medicine 2005, 136-153. Elsevier Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
46. Jouvet M. Recherche sur les structures nerveuses et les mecanismes responsables des differentes phases du sommeil physiologique. Arch Ital Biol 1962, 100:125-206.
47. Jouvet M. Paradoxical sleep mechanisms. Sleep 1994, 17:S77-S83.
48. Kaitin K.I. Proptic area unit activity during sleep and wakefulness in the cat. Exp Neurol 1984, 83:347-357.
49. Kanbayashi T., Kodama T., Hondo H., et al. CSF histamine and noradrenaline contents in narcolepsy and other sleep disorders. Sleep 2004, 27:A236.
50. Karczmar A.G., Longo V.G., De Carolis S. A pharmacological model of paradoxical sleep: the role of cholinergic and monoaminergic systems. Physiol Behav 1970, 5:175-182.
51. Korotkova T.M., Sergeeva O.A., Eriksson K.S., et al. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 2003, 23:7-11.
52. Koyama Y., Hayaishi O. Firing of neurons in the preoptic/anterior hypothalamic areas in rat: its possible involvement in slow wave sleep and paradoxical sleep. Neurosci Res 1994, 19:31-38.
53. Koyama Y., Takahashi K., Kodama T., et al. State-dependent activity of neurons in the perifornical hypothalamic area during sleep and waking. Neuroscience 2003, 119:1209-1219.
54. Kramer A., Yang F.C., Snodgrass P., et al. Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signaling. Science 2001, 294:2511-2515.
55. Krueger J.M., Obal F.J., Fang J., et al. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci 2001, 933:211-221.
56. Lammers G.J., Pijl H., Iestra J., et al. Spontaneous food choice in narcolepsy. Sleep 1996, 19:75-76.
57. Lavie P. Melatonin: role in gating nocturnal rise in sleep propensity. J Biol Rhythms 1997, 12:657-665.
58. Lawrence C.B., Snape A.C., Baudoin F.M., et al. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 2002, 143:155-162.
59. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25:6716-6720.
60. Lin J.-S., Sakai K., Vanni-Mercier G., et al. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol on freely moving cats. Brain Res 1989, 479:225-240.
61. Lin J.S., Sakai K., Vanni-Mercier G., et al. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res 1990, 523:325-330.
62. Lin L., Faraco J., Li R., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
63. Lopez M., Seoane L., Garcia M.C., et al. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 2000, 269:41-45.
64. Lu J., Greco M.A., Shiromani P., et al. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci 2000, 20:3830-3842.
65. Lu J., Bjorkum A.A., Xu M., et al. Selective activation of the extended ventrolateral preoptic nucleus during rapid eye movement sleep. J Neurosci 2002, 22:4568-4576.
66. Marcus J.N., Aschkenasi C.J., Lee C.E., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
67. McCarley R.W., Massaquoi S.G. A limit cycle mathematical model of the REM sleep oscillator system. Am J Physiol 1986, 251:R1011-R1029.
68. McGinty D., Gong H., Suntsova N., et al. Sleep-promoting functions of the hypothalamic median preoptic nucleus: inhibition of arousal systems. Arch Ital Biol 2004, 142:501-509.
69. McGinty D.J., Sterman M.B. Sleep suppression after basal forebrain lesions in the cat. Science 1968, 160:1253-1255.
70. Mignot E., Lammers G.J., Ripley B., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002, 59:1553-1562.
71. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
72. Mochizuki T., Yamatodani A., Okakura K., et al. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol Behav 1992, 51:391-394.
73. Modirrousta M., Mainville L., Jones B.E. Orexin and MCH neurons express c-Fos differently after sleep deprivation vs. recovery and bear different adrenergic receptors. Eur J Neurosci 2005, 21:2807-2816.
74. Monti J.M., Jantos H., Ponzoni A., et al. Sleep and waking during acute histamine H3 agonist BP 2.94 or H3 antagonist carboperamide (MR 16155) administration in rats. Neuropsychopharmacology 1996, 15:31-35.
75. Morse A.D., Russell J.C., Hunt T.W., et al. Diurnal variation of intensive running in food-deprived rats. Can J Physiol Pharmacol 1995, 73:1519-1523.
76. Nauta W.J.H. Hypothalamic regulations of sleep in rats. An experimental study. J Neurophysiol 1946, 9:285-316.
77. Nishino S., Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med Rev 2005, 9:269-310.
78. Nishino S., Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997, 52:27-78.
79. Nishino S., Mignot E. CNS stimulants in sleep medicine: basic mechanisms and pharmacology. Principles and Practice of Sleep Medicine 2005, 468-498. Elsevier Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
80. Nishino S., Fujiki N., Ripley B., et al. Decreased brain histamine contents in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett 2001, 313:125-128.
81. Nishino S., Ripley B., Overeem S., et al. Low CSF hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001, 50:381-388.
82. Nishino S., Sakurai E., Nevisimalova S., et al. CSF histamine content is decreased in hypocretin-deficient human narcolepsy. Sleep 2002, 25(Suppl)):A476.
83. Overeem S., van Hilten J.J., Ripley B., et al. Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology 2002, 58:498-499.
84. Parmentier R., Ohtsu H., Djebbara-Hannas Z., et al. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control. J Neurosci 2002, 22:7695-7711.
85. Peyron C., Tighe D.K., van den Pol A.N., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
86. Piper D.C., Upton N., Smith M.I., et al. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 2000, 12:726-730.
87. Porkka-Heiskanen T., Strecker R.E., Thakkar M., et al. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 1997, 276:1265-1268.
88. Porkka-Heiskanen T., Kalinchuk A., Alanko L., et al. Adenosine, energy metabolism, and sleep. ScientificWorldJournal 2003, 3:790-798.
89. Portas C.M., Thakkar M., Rainnie D.G., et al. Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat. Neuroscience 1997, 79:225-235.
90. Qu D., Ludwig D.S., Gammeltoft S., et al. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
91. Ranson S.W. Somnolence caused by hypothalamic lesions in the monkey. Arch Neurol Psychiatry 1939, 41:1-23.
92. Ripley B., Fujiki N., Okura M., et al. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis 2001, 8:525-534.
93. Ripley B., Overeem S., Fujiki N., et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001, 57:2253-2258.
94. Roehrs T.A., Tietz E.I., Zorick F.J., et al. Daytime sleepiness and antihistamines. Sleep 1984, 7:137-141.
95. Sakai K., El Mansari M., Lin J.G., et al. The posterior hypothalamus in the regulation of wakefulness and paradoxical sleep. The Diencephalon and Sleep 1990, 171-198. Raven Press, New York. M. Mancia, G. Marini (Eds.).
96. Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev 2005, 9:231-241.
97. Sakurai T., Amemiya A., Ishii M., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
98. Saper C.B., Chou T.C., Scammell T.E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001, 24:726-731.
99. Satoh S., Matsumura H., Suzuki F., et al. Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc Natl Acad Sci U S A 1996, 93:5980-5984.
100. Scammell T., Gerashchenko D., Urade Y., et al. Activation of ventrolateral preoptic neurons by the somnogen prostaglandin D2. Proc Natl Acad Sci U S A 1998, 95:7754-7759.
101. Scammell T.E., Estabrooke I.V., McCarthy M.T., et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000, 20:8620-8628.
102. Scammell T.E., Gerashchenko D.Y., Mochizuki T., et al. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 2001, 107:653-663.
103. Sherin J., Shiromani P., McCarley R., et al. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271:216-220.
104. Sherin J.E., Elmquist J.K., Torrealba F., et al. Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 1998, 18:4705-4721.
105. Siegel J.M. REM sleep. Principles and Practice of Sleep Medicine 2005, 120-135. Elsevier Saunders, Philadelphia. 4th edn. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
106. Silver R., LeSauter J., Tresco P.A., et al. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 1996, 382:810-813.
107. Steininger T.L., Alam M.N., Gong H., et al. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res 1999, 840:138-147.
108. Steriade M., McCarley R.W. Brainstem Control of Wakefulness and Sleep 1990, Plenum, New York.
109. Steriade M., Nunez A., Amzica F. A novel slow (< 1 Hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components. J Neurosci 1993, 13:3252-3265.
110. Steriade M., Contreras D., Curro Dossi R., et al. The slow (< 1 Hz) oscillation in reticular thalamic and thalamocortical neurons: scenario of sleep rhythm generation in interacting thalamic and neocortical networks. J Neurosci 1993, 13:3284-3299.
111. Sterman M.B., Clemonte C.D. Forebrain inhibitory mechanisms: cortical synchronization induced by basal forebrain stimulation. Exp Neurol 1962, 6:91-102.
112. Sterman M.B., Clemonte C.D. Forebrain inhibitory mechanisms: sleep pattern by basal forebrain stimulation. Exp Neurol 1962, 6:103-107.
113. Szymusiak R., McGinty D. Sleep-related neuronal discharge in the basal forebrain of cats. Brain Res 1986, 370:82-92.
114. Szymusiak R., McGinty D. Sleep suppression following kainic acid-induced lesions of the basal forebrain. Exp Neurol 1986, 94:598-614.
115. Szymusiak R., Alam N., Steininger T.L., et al. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998, 803:178-188.
116. Taheri S., Sunter D., Dakin C., et al. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett 2000, 279:109-112.
117. Takahashi J.S. Molecular neurobiology and genetics of circadian rhythms in mammals. Annu Rev Neurosci 1995, 18:531-553.
118. Taylor M.M., Samson W.K. The other side of the orexins: endocrine and metabolic actions. Am J Physiol Endocrinol Metab 2003, 284:E13-E17.
119. Terao A., Peyron C., Ding J., et al. Prepro-hypocretin (prepro-orexin) expression is unaffected by short-term sleep deprivation in rats and mice. Sleep 2000, 23:867-874.
120. Thannickal T.C., Moore R.Y., Nienhuis R., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
121. Tohyama J., Kanazawa O., Akasaka N., et al. A case of bilateral paramedian thalamic infarction in childhood with the sensory disturbance and the sensory loss of taste. No To Hattatsu 2004, 36:65-69.
122. Ueno R., Hayaishi O., Osama H., et al. Prostaglandin D2 regulates physiological sleep. Endogenous Sleep Substances and Sleep Regulation 1985, 193-201. Japan Scientific Societies Press, Tokyo. S. Inoué, A. Borbely (Eds.).
123. Verret L., Goutagny R., Fort P., et al. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 2003, 4:19.
124. Von Economo C. Encephalitis Lethargica: Its Sequelae and Treatment (trans. KO Newman) 1931, Oxford University Press, Oxford.
125. Watts A.G., Swanson L.W. Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 1987, 258:230-252.
126. Watts A.G., Swanson L.W., Sanchez-Watts G. Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J Comp Neurol 1987, 258:204-229.
127. Welsh D., Richardson G.S., Dement W.C. Effect of running wheel availability on circadian patterns of sleep and wakefulness in mice. Physiol Behav 1988, 43:771-777.
128. Willie J.T., Chemelli R.M., Sinton C.M., et al. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 2001, 24:429-458.
129. Willie J.T., Chemelli R.M., Sinton C.M., et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003, 38:715-730.
130. Winsky-Sommerer R., Yamanaka A., Diano S., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 2004, 24:11439-11448.
131. Yamamoto Y., Ueta Y., Date Y., et al. Down regulation of the prepro-orexin gene expression in genetically obese mice. Mol Brain Res 1999, 65:14-22.
132. Yamanaka A., Tsujino N., Funahashi H., et al. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002, 290:1237-1245.
133. Yamanaka A., Muraki Y., Tsujino N., et al. Regulation of orexin neurons by the monoaminergic and cholinergic systems. Biochem Biophys Res Commun 2003, 303:120-129.
134. Yamanaka A., Beuckmann C.T., Willie J.T., et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
135. Yanai K., Son L.Z., Endou M., et al. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 1998, 87:479-487.
136. Yoshida Y., Fujiki N., Nakajima T., et al. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur J Neurosci 2001, 14:1075-1081.
137. Yoshida Y., Fujiki N., Maki R.A., et al. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats. Neurosci Lett 2003, 346:182-186.
138. Yoshida Y., Nishino S., Ishizuka T., et al. Vigilance change, hypocretin and histamine release in rats before and after a histamine synthesis blocker (alpha-FMH) administration. Sleep 2005, 28:A18.
139. Yoshikawa S., Suzuki S., Kanbayashi T., et al. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis. Pediatr Neurol 2004, 31:367-370.
140. Zeitzer J.M., Buckmaster C.L., Parker K.J., et al. Circadian and homeostatic regulation of hypocretin in a primate model: implications for the consolidation of wakefulness. J Neurosci 2003, 23:3555-3560.
141. Zepelin H. Mammalian sleep. Principles and Practice of Sleep Medicine 1994, 81-94. W. B. Saunders, Philadelphia. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
142. Zhang S., Zeitzer J.M., Yoshida Y., et al. Lesions of the suprachiasmatic nucleus eliminate the daily rhythm of hypocretin-1 release. Sleep 2004, 27:619-627.